21 May 2009
Evaluation differents immunosuppressive protocols in patients after kidney transplantation
L Zair, T Sulikowski, M Kamiński, Z Ziętek, S Zeair, A Sierocka, K Tejchman, M Wiśniowski, M Szałata, K Kłoda, M OstrowskiAnn Transplant 2009; 14(1): 51-51 :: ID: 880386
Abstract
Prevention and control of renal allograft rejection have been some of the main problems since the first kidney transplant. Common use of selective immunosuppressive agents became an effective and safe way of treatment Nevertheless comparing immunosuppressive protocols containing different
types of drugs is still a pivotal aim of many studies. Here we are presenting the experience from two different centres in Szczecin.The aim of our study was to compare two immunosuppressive protocols: Tac MMF steroids with Cs Aza steroids and their efficacy, incidence of acute rejection, side effects, incidence of IGF, DGF and serum creatinine concentrations after 1 month and 1 year. We have investigated medical records of 1248 patients, treated between the years 1990-2007 in two different centres in Szczecin. 553 patients were selected and divided into two groups - Tac MMF steroids protocol recipients (n=135) and Cs Aza steroids protocol recipients (n=418). We observed higher incidence of IGF with Tac MMF steroids protocol use, and higher incidence of DGF with Cs Aza steroids protocol use. There were no significant differences between immunosuppressive protocols and patients gender in regard to episodes of acute rejection. The incidence of acute rejection was higher in younger patients. Side effects after immunosuppressive treatment were more common in Tac MMF steroids protocol recipients and in younger patients. There were no significant differences between the serum creatinine concentrations after 1 month and 1 year in regard to both of the protocols.
Keywords: Immunosuppression, Kidney Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860